Skip to main content

Table 1 The baseline characteristics of participants

From: A nonlinear relationship between the triglycerides to high-density lipoprotein cholesterol ratio and stroke risk: an analysis based on data from the China Health and Retirement Longitudinal Study

TG/HDL-C ratio

Q1 (≤ 1.32)

Q2 (1.32 to ≤ 2.11)

Q3 (2.11 to ≤ 3.56)

Q4 (> 3.56)

P-value

Participants

2539

2542

2542

2541

 

Gender

< 0.001b

 Male

1317 (51.87%)

1173 (46.14%)a

1126 (44.30%)a

1130 (44.47%)a

 

 Female

1222 (48.13%)

1369 (53.86%)

1416 (55.70%)

1411 (55.53%)

 

Age (years)

59.89 ± 9.76

59.32 ± 9.48a

59.04 ± 9.11a

58.45 ± 8.96a

< 0.001d

Drinking status

< 0.001b

 Never drinkers

312 (12.29%)

350 (13.77%)a

378 (14.87%)a

344 (13.54%)a

 

 Ever drinkers

1398 (55.06%)

1580 (62.16%)

1609 (63.30%)

1633 (64.27%)

 

 Current drinkers

829 (32.65%)

612 (24.08%)

555 (21.83%)

564 (22.20%)

 

Smoking status

< 0.001b

 Never smokers

1469 (57.86%)

1571 (61.80%)a

1605 (63.14%)a

1605 (63.16%)a

 

 Ever smokers

221 (8.70%)

204 (8.03%)

217 (8.54%)

240 (9.45%)

 

 Current smokers

849 (33.44%)

767 (30.17%)

720 (28.32%)

696 (27.39%)

 

Physical activity

< 0.001b

 No

790 (31.11%)

896 (35.25%)a

945 (37.18%)a

962 (37.86%)a

 

 Yes

1749 (68.89%)

1646 (64.75%)

1597 (62.82%)

1579 (62.14%)

 

Drugs for cardiovascular prevention

< 0.001b

 No

2379 (93.70%)

2359 (92.80%)

2338 (91.97%)a

2280 (89.73%)a

 

 Yes

160 (6.30%)

183 (7.20%)

204 (8.03%)

261 (10.27%)

 

Hypertension

< 0.001b

 No

1678 (66.09%)

1589 (62.51%)a

1409 (55.43%)a

1249 (49.15%)a

 

 Yes

861 (33.91%)

953 (37.49%)

1133 (44.57%)

1292 (50.85%)

 

SBP (mmHg)

128.03 ± 21.01

129.23 ± 20.94a

131.77 ± 21.70a

133.32 ± 21.31a

0.011d

DBP (mmHg)

73.98 ± 12.04

74.83 ± 11.71a

76.45 ± 12.15a

77.98 ± 12.01a

< 0.001d

BMI (kg/m2)

22.08 ± 3.42

22.98 ± 3.83a

24.00 ± 3.95a

25.04 ± 3.89a

< 0.001d

TG/HDL-C ratio

0.96 ± 0.23

1.69 ± 0.23a

2.73 ± 0.41a

6.41 ± 3.13a

< 0.001d

HDL-C (mg/dL)

67.26 ± 14.34

54.13 ± 10.12a

46.88 ± 8.66a

37.56 ± 7.91a

< 0.001d

TG (mg/dL)

62.59 ± 15.09

91.13 ± 18.44a

127.07 ± 26.02a

229.07 ± 89.30a

 < 0.001d

LDL-C (mg/dL)

111.06 ± 29.89

119.04 ± 32.66a

123.42 ± 34.41a

113.94 ± 37.98a

< 0.001d

TC (mg/dL)

188.07 ± 34.74

189.16 ± 36.70

194.14 ± 37.53a

200.17 ± 41.83a

< 0.001d

CRP (mg/L)

0.75 (0.44–1.74)

0.91 (0.52–1.88)a

1.08 (0.58–2.25)a

1.32 (0.72–2.63)a

< 0.001c

Scr (mg/dL)

0.78 ± 0.32

0.77 ± 0.22

0.78 ± 0.20

0.80 ± 0.20a

< 0.001d

FPG (mg/dL)

102.23 ± 23.48

105.34 ± 28.41a

109.09 ± 34.61a

120.99 ± 45.84a

< 0.001d

HbA1c (%)

5.13 ± 0.61

5.19 ± 0.70a

5.25 ± 0.82a

5.40 ± 0.98a

< 0.001d

Cystatin C (mg/L)

1.01 ± 0.31

1.03 ± 0.27

1.01 ± 0.27

0.96 ± 0.26a

< 0.001d

UA (mg/dL)

4.24 ± 1.16

4.32 ± 1.22a

4.45 ± 1.24a

4.79 ± 1.31a

< 0.001d

  1. Values are n (%) or mean ± SD or median (quartile)
  2. TG/HDL-C ratio ratio of triglyceride to high-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, TG triglycerides, Scr serum creatinine, CRP C-reactive protein, FPG fasting plasma glucose, HbA1c glycosylated hemoglobin, UA uric acid
  3. aRepresents other groups (Q2, Q3, Q4) compared with Q1, P < 0.05
  4. bUsed the χ2 test
  5. cApplied the Kruskal–Wallis
  6. dUsed the one-way ANOVA test